Strategic Initiative

Slingshot members are tracking this corporate initiative:

Regeneron (REGN) and Alnylam (ALNY) Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases

Source Link:
https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-alnylam-announce-broad-collaboration-discover

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
REGN
100%
ALNY
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Apr 08, 2019
Projected Implementation:
Q2, 2019
Relevance Tracked Until:
Q1, 2020
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Cns, Ocular Diseases, Rnai-based Therapy
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.